Search Results - "Yi, Kaikai"
-
1
Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy
Published in Advanced materials (Weinheim) (01-12-2019)“…The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR‐associated (Cas) enzyme, Cas13a, holds great promise in cancer treatment due to…”
Get full text
Journal Article -
2
EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas
Published in Cancer letters (10-10-2017)“…The epidermal growth factor receptor (EGFR) frequently undergoes high-level genomic amplification and variant III (vIII) deletion in adult glioblastoma…”
Get full text
Journal Article -
3
Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy
Published in Theranostics (01-01-2020)“…Developing an effective nanoplatform to realize 'multi-in-one' is essential to broaden the therapeutic potential of combination therapy. Exosomes are ideal…”
Get full text
Journal Article -
4
Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery
Published in Macromolecular bioscience (01-08-2021)“…Exosomes derived from non‐tumor cells hold great potential as drug delivery vehicles because of their good biosafety and natural transference of bioactive…”
Get full text
Journal Article -
5
FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury
Published in Redox biology (01-01-2021)“…Autophagy of mitochondria, termed mitophagy, plays an important role in cerebral ischemia-reperfusion (IR) injury, but the mechanism is not yet clear…”
Get full text
Journal Article -
6
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
Published in Cell death & disease (21-11-2019)“…Runt-Related Transcription Factor 1 (RUNX1) is highly expressed in the Mesenchymal (Mes) subtype of glioblastoma (GBM). However, the specific molecular…”
Get full text
Journal Article -
7
The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells
Published in Advanced science (01-10-2019)“…RNA is rarely used as a therapeutic target due to its flexible structure and instability. CRISPR‐Cas13a is a powerful tool for RNA knockdown, and the potential…”
Get full text
Journal Article -
8
TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma
Published in Theranostics (01-01-2022)“…Glioblastoma (GBM) displays a complex metabolic reprogramming in cancer cells. Adenosine triphosphate (ATP) is one of the central mediators of cell metabolism…”
Get full text
Journal Article -
9
Tumor Microenvironment‐Tailored Weakly Cell‐Interacted Extracellular Delivery Platform Enables Precise Antibody Release and Function
Published in Advanced functional materials (01-10-2019)“…Precise delivery of extracellularly functional protein drugs is limited by the drawback in that the protective carrier often causes undesirable cellular uptake…”
Get full text
Journal Article -
10
The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes
Published in Theranostics (01-01-2018)“…Exosomes play critical roles in intercellular communication in both nearby and distant cells in individuals and organs. Polymerase I and transcript release…”
Get full text
Journal Article -
11
HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas
Published in Frontiers in immunology (23-11-2021)“…Checkpoint blockade therapies targeting programmed death ligand 1 (PD-L1) and its receptor programmed cell death 1 promote T cell-mediated immune surveillance…”
Get full text
Journal Article -
12
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep
Published in Theranostics (01-01-2019)“…Over 20% of cancer 'driver' genes encode chromatin regulators. Long noncoding RNAs (lincRNAs), which are dysregulated in various cancers, play a critical role…”
Get full text
Journal Article -
13
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
Published in Frontiers in immunology (06-01-2022)“…Immunotherapy, especially checkpoint inhibitors targeting PD-1 or PD-L1, has revolutionized cancer therapy. However, PD-1/PD-L1 inhibitors have not been…”
Get full text
Journal Article -
14
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy
Published in Frontiers in oncology (29-04-2022)“…Glioblastoma (GBM) is the most common and lethal type of primary malignant central nervous system (CNS) tumor with an extremely poor prognosis, and the…”
Get full text
Journal Article -
15
EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression
Published in Clinical and translational medicine (28-01-2020)“…Background The EGFR-vIII mutation is the most common malignant event in GBM. Epigenetic reprogramming in EGFR-activated GBM has recently been suggested to…”
Get full text
Journal Article -
16
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
Published in Cancer communications (London, England) (01-12-2023)“…Background Metabolism reprogramming plays a vital role in glioblastoma (GBM) progression and recurrence by producing enough energy for highly proliferating…”
Get full text
Journal Article -
17
Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
Published in Biomaterials (01-11-2020)“…The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (Cas9) system holds great promise for the cancer gene therapy…”
Get full text
Journal Article -
18
Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy
Published in Neuro-oncology (Charlottesville, Va.) (02-11-2022)“…Targeting glioblastoma (GBM) energy metabolism through multiple metabolic pathways has emerged as an effective therapeutic approach. Dual inhibition of…”
Get full text
Journal Article -
19
Glioma-derived exosomes hijack the blood–brain barrier to facilitate nanocapsule delivery via LCN2
Published in Journal of controlled release (01-05-2022)“…Exosomes are small extracellular vehicles which could transport genetic materials and proteins between cells. Although there are reports about exosomes…”
Get full text
Journal Article -
20
PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2
Published in Neuro-oncology (Charlottesville, Va.) (25-03-2021)“…Abstract Background Metabolism remodeling is a hallmark of glioblastoma (GBM) that regulates tumor proliferation and the immune microenvironment. Previous…”
Get full text
Journal Article